Skip to main content

ADVERTISEMENT

Amanda Balbi

News
06/29/2023
This approval comes after a safety and effectiveness trial showed that the treatment improved participants’ annualized bleeding rate after 3 years.
This approval comes after a safety and effectiveness trial showed that the treatment improved participants’ annualized bleeding rate after 3 years.
This approval comes after a...
06/29/2023
Population Health
News
05/25/2023
Three other medications are approved for treating this population, but none are administered orally.
Three other medications are approved for treating this population, but none are administered orally.
Three other medications are...
05/25/2023
Infectious Diseases
vaccine with syringe
Podcast
05/20/2022
Dr Winthrop talks about how vaccinations affect individuals with immunocompromised immune systems, the challenges associated with vaccination, and what rheumatologists should know about vaccines in 2020.
Dr Winthrop talks about how vaccinations affect individuals with immunocompromised immune systems, the challenges associated with vaccination, and what rheumatologists should know about vaccines in 2020.
Dr Winthrop talks about how...
05/20/2022
Rheumatology & Arthritis
Can Vitamin C Improve BMD, Reduce Osteoporosis Risk?
08/27/2020
Vitamin C supplementation may not prevent osteoporosis or fractures related to reduced bone mineral density, according to results of a new literature review.
Vitamin C supplementation may not prevent osteoporosis or fractures related to reduced bone mineral density, according to results of a new literature review.
Vitamin C supplementation may...
08/27/2020
Rheumatology & Arthritis
NAFLD Is Associated With an Increased Risk of MACE
Conference Coverage
07/01/2020
Preliminary results of the PROMISE trial highlight the relationship between nonalcoholic fatty liver disease and cardiovascular disease, which has been debated previously.
Preliminary results of the PROMISE trial highlight the relationship between nonalcoholic fatty liver disease and cardiovascular disease, which has been debated previously.
Preliminary results of the...
07/01/2020
Gastroenterology
New Studies Investigate Connection Between NAFLD and CVD
Conference Coverage
07/01/2020
For her session at the 21st Annual Harvard Nutrition and Obesity Symposium on NAFLD, Kathleen Corey, MD, MPH, MMSc, highlighted her research on the connection between NAFLD and cardiovascular disease.
For her session at the 21st Annual Harvard Nutrition and Obesity Symposium on NAFLD, Kathleen Corey, MD, MPH, MMSc, highlighted her research on the connection between NAFLD and cardiovascular disease.
For her session at the 21st...
07/01/2020
Gastroenterology
Can the ASCVD Risk Score Accurately Predict MACE Among Patients With NAFLD?
Conference Coverage
07/01/2020
In a study presented at the 21st Annual Harvard Nutrition and Obesity Symposium, Kathleen E. Corey, MD, spoke about the risk factors for cardiovascular disease and MACE among patients with NAFLD.
In a study presented at the 21st Annual Harvard Nutrition and Obesity Symposium, Kathleen E. Corey, MD, spoke about the risk factors for cardiovascular disease and MACE among patients with NAFLD.
In a study presented at the 21st...
07/01/2020
Gastroenterology
NAFLD, NASH Is Becoming More Prevalent Worldwide
Conference Coverage
07/01/2020
Nonalcoholic steatohepatitis is a potentially progressive form of nonalcoholic fatty liver disease. Recent research, which was discussed at the 21st Annual Harvard Nutrition and Obesity Symposium on NAFLD, shows an increasing burden of these...
Nonalcoholic steatohepatitis is a potentially progressive form of nonalcoholic fatty liver disease. Recent research, which was discussed at the 21st Annual Harvard Nutrition and Obesity Symposium on NAFLD, shows an increasing burden of these...
Nonalcoholic steatohepatitis is...
07/01/2020
Gastroenterology
Factors Affecting Vertebral Fragility Fracture Risk Are Identified
05/26/2020
Age, gender, and bone mineral density (BMD) are all significant risk factors that impact vertebral fragility fracture risk among middle-aged and older individuals, according to new data. These conclusions arise...
Age, gender, and bone mineral density (BMD) are all significant risk factors that impact vertebral fragility fracture risk among middle-aged and older individuals, according to new data. These conclusions arise...
Age,...
05/26/2020
Rheumatology & Arthritis
George Karpouzas, MD, on β-2 Glycoprotein 1 IgA Antibodies and Coronary Outcomes in RA
RHEUMATOLOGY
05/18/2020
Dr Karpouzas discusses his research that evaluated whether β-2 glycoprotein 1 IgA antibodies can predict coronary plaque burden and progression, and whether the antibodies moderate the effect of inflammation on atherosclerosis among patients...
Dr Karpouzas discusses his research that evaluated whether β-2 glycoprotein 1 IgA antibodies can predict coronary plaque burden and progression, and whether the antibodies moderate the effect of inflammation on atherosclerosis among patients...
Dr Karpouzas discusses his...
05/18/2020
Rheumatology & Arthritis